Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(12): 232-242


Network Pharmacology Study of Phyllanthus niruri: Potential Target Proteins and Their Hepatoprotective Activities

Santi Tan, Adi Yulandi, Raymond Rubianto Tjandrawinata.




Abstract
Cited by 0 Articles

This study aimed to investigate the potential target proteins, the crucial components of
Phyllanthus niruri, and the molecular mechanisms involved in hepatoprotective activities by
using network pharmacology and molecular docking approaches. In addition, the activities of
bioactive components obtained were compared to those of Curcuma longa and Curcuma
xanthorrhiza. Nine potential target proteins, namely AKT1, JUN, VEGFA, EGFR, CCND1,
SRC, CREB1, MMP2, and RELA, and two crucial components of P. niruri, namely ellagic acid
and quercetin, which have potential hepatoprotective activities, were identified. This network pharmacology study showed that P. niruri affected liver tissues mainly through ten biological processes and seven signaling pathways that could be classified into anti-inflammatory and antioxidant activities. The molecular docking study confirmed these activities, which demonstrated the high binding activity in all ligands and receptors. Among the nine target proteins, CCND1 and RELA were determined as the key targets of P. niruri in hepatoprotective activities. We can conclude that P. niruri has the potential to be a promising new hepatoprotective agent.

Key words: Phyllanthus niruri, hepatoprotective, network pharmacology, potential target protein, molecular mechanism






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.